Annual CFF
$73.88 M
+$74.77 M+8335.79%
December 31, 2023
Summary
- As of February 7, 2025, ADCT annual cash flow from financing activities is $73.88 million, with the most recent change of +$74.77 million (+8335.79%) on December 31, 2023.
- During the last 3 years, ADCT annual CFF has fallen by -$421.09 million (-85.07%).
- ADCT annual CFF is now -85.07% below its all-time high of $494.97 million, reached on December 31, 2020.
Performance
ADCT Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$879.00 K
-$99.58 M-100.89%
September 30, 2024
Summary
- As of February 7, 2025, ADCT quarterly cash flow from financing activities is -$879.00 thousand, with the most recent change of -$99.58 million (-100.89%) on September 30, 2024.
- Over the past year, ADCT quarterly CFF has dropped by -$878.00 thousand (-87800.00%).
- ADCT quarterly CFF is now -100.29% below its all-time high of $306.83 million, reached on June 30, 2020.
Performance
ADCT Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$98.17 M
-$1.23 M-1.24%
September 30, 2024
Summary
- As of February 7, 2025, ADCT TTM cash flow from financing activities is $98.17 million, with the most recent change of -$1.23 million (-1.24%) on September 30, 2024.
- Over the past year, ADCT TTM CFF has increased by +$24.30 million (+32.89%).
- ADCT TTM CFF is now -80.28% below its all-time high of $497.84 million, reached on September 30, 2020.
Performance
ADCT TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
ADCT Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +8335.8% | -10000.0% | +32.9% |
| 3 y3 years | -85.1% | +27.8% | -63.3% |
| 5 y5 years | +10000.0% | +27.8% | -63.3% |
ADCT Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -72.4% | +8335.8% | -100.9% | +68.1% | -63.3% | >+9999.0% |
| 5 y | 5-year | -85.1% | +8335.8% | -100.3% | +69.4% | -80.3% | >+9999.0% |
| alltime | all time | -85.1% | +8335.8% | -100.3% | +69.4% | -80.3% | >+9999.0% |
ADC Therapeutics SA Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$879.00 K(-100.9%) | $98.17 M(-1.2%) |
| Jun 2024 | - | $98.70 M(>+9900.0%) | $99.40 M(+34.7%) |
| Mar 2024 | - | $356.00 K(<-9900.0%) | $73.81 M(-0.1%) |
| Dec 2023 | $73.88 M(-8335.8%) | -$1000.00(-100.3%) | $73.88 M(+3.9%) |
| Sep 2023 | - | $349.00 K(-99.5%) | $71.12 M(-2.8%) |
| Jun 2023 | - | $73.10 M(>+9900.0%) | $73.14 M(<-9900.0%) |
| Mar 2023 | - | $425.00 K(-115.4%) | -$214.00 K(-76.1%) |
| Dec 2022 | -$897.00 K(-100.3%) | -$2.75 M(-216.4%) | -$897.00 K(-240.8%) |
| Sep 2022 | - | $2.37 M(-1038.5%) | $637.00 K(-99.7%) |
| Jun 2022 | - | -$252.00 K(-2.3%) | $217.58 M(-18.6%) |
| Mar 2022 | - | -$258.00 K(-78.8%) | $267.43 M(+0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $267.39 M(-46.0%) | -$1.22 M(-100.6%) | $267.39 M(+0.6%) |
| Sep 2021 | - | $219.30 M(+342.1%) | $265.74 M(+11.8%) |
| Jun 2021 | - | $49.60 M(<-9900.0%) | $237.72 M(-52.0%) |
| Mar 2021 | - | -$297.00 K(-89.7%) | $494.95 M(-0.0%) |
| Dec 2020 | $494.97 M(+392.4%) | -$2.87 M(-101.5%) | $494.97 M(-0.6%) |
| Sep 2020 | - | $191.28 M(-37.7%) | $497.84 M(+62.4%) |
| Jun 2020 | - | $306.83 M(<-9900.0%) | $306.56 M(<-9900.0%) |
| Mar 2020 | - | -$278.00 K | -$278.00 K |
| Dec 2019 | $100.51 M(<-9900.0%) | - | - |
| Dec 2018 | -$24.00 K(-100.0%) | - | - |
| Dec 2017 | $197.24 M | - | - |
FAQ
- What is ADC Therapeutics SA annual cash flow from financing activities?
- What is the all time high annual CFF for ADC Therapeutics SA?
- What is ADC Therapeutics SA annual CFF year-on-year change?
- What is ADC Therapeutics SA quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for ADC Therapeutics SA?
- What is ADC Therapeutics SA quarterly CFF year-on-year change?
- What is ADC Therapeutics SA TTM cash flow from financing activities?
- What is the all time high TTM CFF for ADC Therapeutics SA?
- What is ADC Therapeutics SA TTM CFF year-on-year change?
What is ADC Therapeutics SA annual cash flow from financing activities?
The current annual CFF of ADCT is $73.88 M
What is the all time high annual CFF for ADC Therapeutics SA?
ADC Therapeutics SA all-time high annual cash flow from financing activities is $494.97 M
What is ADC Therapeutics SA annual CFF year-on-year change?
Over the past year, ADCT annual cash flow from financing activities has changed by +$74.77 M (+8335.79%)
What is ADC Therapeutics SA quarterly cash flow from financing activities?
The current quarterly CFF of ADCT is -$879.00 K
What is the all time high quarterly CFF for ADC Therapeutics SA?
ADC Therapeutics SA all-time high quarterly cash flow from financing activities is $306.83 M
What is ADC Therapeutics SA quarterly CFF year-on-year change?
Over the past year, ADCT quarterly cash flow from financing activities has changed by -$878.00 K (-87800.00%)
What is ADC Therapeutics SA TTM cash flow from financing activities?
The current TTM CFF of ADCT is $98.17 M
What is the all time high TTM CFF for ADC Therapeutics SA?
ADC Therapeutics SA all-time high TTM cash flow from financing activities is $497.84 M
What is ADC Therapeutics SA TTM CFF year-on-year change?
Over the past year, ADCT TTM cash flow from financing activities has changed by +$24.30 M (+32.89%)